{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:08:29Z","timestamp":1788314909500,"version":"build-2803163510"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA252969"],"award-info":[{"award-number":["1R01CA252969"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM124020"],"award-info":[{"award-number":["R01GM124020"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM142520"],"award-info":[{"award-number":["T32GM142520"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM142520"],"award-info":[{"award-number":["T32GM142520"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM142520"],"award-info":[{"award-number":["T32GM142520"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41417-026-01029-4","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:55:26Z","timestamp":1776322526000},"page":"861-874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Amitriptyline inhibits EAG1 channels by binding to their PAS domains and exerts EAG1-dependent anti-tumorigenic effects"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7255-2750","authenticated-orcid":false,"given":"Joos","family":"Berghausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementine A. D.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Kihn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7729-3954","authenticated-orcid":false,"given":"Eric","family":"Glasgow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3046-8184","authenticated-orcid":false,"given":"Tinatin I.","family":"Brelidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"1029_CR1","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1073\/pnas.91.8.3438","volume":"91","author":"JW Warmke","year":"1994","unstructured":"Warmke JW, Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA. 1994;91:3438\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1029_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.aaf8070","volume":"353","author":"JR Whicher","year":"2016","unstructured":"Whicher JR, MacKinnon R. Structure of the voltage-gated K+ channel Eag1 reveals an alternative voltage sensing mechanism. Science. 2016;353:664\u20139.","journal-title":"Science"},{"key":"1029_CR3","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49188","volume":"8","author":"JR Whicher","year":"2019","unstructured":"Whicher JR, MacKinnon R. Regulation of Eag1 gating by its intracellular domains. Elife. 2019;8:e49188.","journal-title":"Elife"},{"key":"1029_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1006\/mcne.2000.0851","volume":"16","author":"J Ludwig","year":"2000","unstructured":"Ludwig J, Weseloh R, Karschin C, Liu Q, Netzer R, Engeland B, et al. Cloning and functional expression of rat eag2, a new member of the ether-\u00e0-go-go family of potassium channels and comparison of its distribution with that of eag1. Mol Cell Neurosci. 2000;16:59\u201370.","journal-title":"Mol Cell Neurosci"},{"key":"1029_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1113\/jphysiol.2014.281600","volume":"593","author":"LS Mortensen","year":"2015","unstructured":"Mortensen LS, Schmidt H, Farsi Z, Barrantes-Freer A, Rubio ME, Ufartes R, et al. KV10.1 opposes activity-dependent increase in Ca2+ influx into the presynaptic terminal of the parallel fibre\u2013Purkinje cell synapse. J Physiol. 2015;593:181\u201396.","journal-title":"J Physiol"},{"key":"1029_CR6","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/cancers12092409","volume":"12","author":"N Movsisyan","year":"2020","unstructured":"Movsisyan N, Pardo LA. Kv10.1 regulates microtubule dynamics during mitosis. Cancers (Basel). 2020;12:2409.","journal-title":"Cancers (Basel)"},{"key":"1029_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/med.21808","volume":"42","author":"\u017d Toplak","year":"2022","unstructured":"Toplak \u017d, Hendrickx LA, Abdelaziz R, Shi X, Peigneur S, Toma\u0161i\u010d T, et al. Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment. Med Res Rev. 2022;42:183\u2013226.","journal-title":"Med Res Rev"},{"key":"1029_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-42","volume":"5","author":"F Mello de Queiroz","year":"2006","unstructured":"Mello de Queiroz F, Suarez-Kurtz G, St\u00fchmer W, Pardo LA. Ether \u00e0 go-go potassium channel expression in soft tissue sarcoma patients. Mol Cancer. 2006;5:42.","journal-title":"Mol Cancer"},{"key":"1029_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-41","volume":"5","author":"B Hemmerlein","year":"2006","unstructured":"Hemmerlein B, Weseloh RM, Mello de Queiroz F, Kn\u00f6tgen H, S\u00e1nchez A, Rubio ME, et al. Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer. 2006;5:41.","journal-title":"Mol Cancer"},{"key":"1029_CR10","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.3390\/s120505986","volume":"12","author":"JA Rodr\u00edguez-Rasgado","year":"2012","unstructured":"Rodr\u00edguez-Rasgado JA, Acu\u00f1a-Mac\u00edas I, Camacho J. Eag1 Channels as potential cancer biomarkers. Sens (Basel). 2012;12:5986\u201395.","journal-title":"Sens (Basel)"},{"key":"1029_CR11","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1093\/emboj\/18.20.5540","volume":"18","author":"LA Pardo","year":"1999","unstructured":"Pardo LA, del Camino D, S\u00e1nchez A, Alves F, Br\u00fcggemann A, Beckh S, et al. Oncogenic potential of EAG K(+) channels. EMBO J. 1999;18:5540\u20137.","journal-title":"EMBO J"},{"key":"1029_CR12","doi-asserted-by":"publisher","first-page":"13030","DOI":"10.1074\/jbc.M600883200","volume":"281","author":"C Weber","year":"2006","unstructured":"Weber C, de Queiroz FM, Downie BR, Suckow A, St\u00fchmer W, Pardo LA. Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference. J Biol Chem. 2006;281:13030\u20137.","journal-title":"J Biol Chem"},{"key":"1029_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114673","volume":"162","author":"C Xia","year":"2023","unstructured":"Xia C, Liu C, Ren S, Cai Y, Zhang Q, Xia C. Potassium channels, tumorigenesis and targeted drugs. Biomed Pharmacother. 2023;162:114673.","journal-title":"Biomed Pharmacother"},{"key":"1029_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41388-020-01522-6","volume":"40","author":"J Chen","year":"2021","unstructured":"Chen J, Xuan Z, Song W, Han W, Chen H, Du Y, et al. EAG1 enhances hepatocellular carcinoma proliferation by modulating SKP2 and metastasis through pseudopod formation. Oncogene. 2021;40:163\u201376.","journal-title":"Oncogene"},{"key":"1029_CR15","unstructured":"The Skp2 Pathway: A Critical Target for Cancer Therapy - PMC [Internet]. [cited 2023 Feb 20]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9201937\/"},{"key":"1029_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/617316","volume":"2015","author":"X Wu","year":"2015","unstructured":"Wu X, Chen Z, Zeng W, Zhong Y, Liu Q, Wu J. Silencing of Eag1 gene inhibits osteosarcoma proliferation and migration by targeting STAT3-VEGF pathway. Biomed Res Int. 2015;2015:617316.","journal-title":"Biomed Res Int"},{"key":"1029_CR17","doi-asserted-by":"publisher","first-page":"12573","DOI":"10.3390\/ijms131012573","volume":"13","author":"J Wu","year":"2012","unstructured":"Wu J, Wu X, Zhong D, Zhai W, Ding Z, Zhou Y. Short hairpin RNA (shRNA) Ether \u00e0 go-go 1 (Eag1) inhibition of human osteosarcoma angiogenesis via VEGF\/PI3K\/AKT Signaling. Int J Mol Sci. 2012;13:12573\u201383.","journal-title":"Int J Mol Sci"},{"key":"1029_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000088478","volume":"69","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69:4\u201310.","journal-title":"Oncology"},{"key":"1029_CR19","first-page":"2959","volume":"8","author":"I Acu\u00f1a-Mac\u00edas","year":"2015","unstructured":"Acu\u00f1a-Mac\u00edas I, Vera E, V\u00e1zquez-S\u00e1nchez AY, Mendoza-Garrido ME, Camacho J. Differential regulation of human Eag1 channel expression by serum and epidermal growth factor in lung and breast cancer cells. Onco Targets Ther. 2015;8:2959\u201365.","journal-title":"Onco Targets Ther"},{"key":"1029_CR20","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1093\/hmg\/ddt076","volume":"22","author":"R Ufartes","year":"2013","unstructured":"Ufartes R, Schneider T, Mortensen LS, de Juan Romero C, Hentrich K, Knoetgen H, et al. Behavioural and functional characterization of Kv10.1 (Eag1) knockout mice. Hum Mol Genet. 2013;22:2247\u201362.","journal-title":"Hum Mol Genet"},{"key":"1029_CR21","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1074\/jbc.RA119.012377","volume":"295","author":"ZJ Wang","year":"2020","unstructured":"Wang ZJ, Soohoo SM, Tiwari PB, Piszczek G, Brelidze TI. Chlorpromazine binding to the PAS domains uncovers the effect of ligand modulation on EAG channel activity. J Biol Chem. 2020;295:4114\u201323.","journal-title":"J Biol Chem"},{"key":"1029_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105391","volume":"299","author":"ZJ Wang","year":"2023","unstructured":"Wang ZJ, Ghorbani M, Chen X, Tiwari PB, Klauda JB, Brelidze TI. Molecular mechanism of EAG1 channel inhibition by imipramine binding to the PAS domain. J Biol Chem. 2023;299:105391.","journal-title":"J Biol Chem"},{"key":"1029_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jpainsymman.2007.02.043","volume":"35","author":"AL Kautio","year":"2008","unstructured":"Kautio AL, Haanp\u00e4\u00e4 M, Saarto T, Kalso E. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manag. 2008;35:31\u20139.","journal-title":"J Pain Symptom Manag"},{"key":"1029_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","volume":"96","author":"SH Sindrup","year":"2005","unstructured":"Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005;96:399\u2013409.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1029_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40360-019-0324-8","volume":"20","author":"ZJ Wang","year":"2019","unstructured":"Wang ZJ, Tiwari PB, \u00dcren A, Brelidze TI. Identification of undecylenic acid as EAG channel inhibitor using surface plasmon resonance-based screen of KCNH channels. BMC Pharm Toxicol. 2019;20:42.","journal-title":"BMC Pharm Toxicol"},{"key":"1029_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-0716-3818-7_7","volume":"2796","author":"PB Tiwari","year":"2024","unstructured":"Tiwari PB, Kamgar-Dayhoff P, Tiwari P, McKillop MI, Brelidze TI. Use of surface plasmon resonance technique for studies of inter-domain interactions in ion channels. Methods Mol Biol. 2024;2796:105\u201318.","journal-title":"Methods Mol Biol"},{"key":"1029_CR27","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem 2025 update. Nucleic Acids Res. 2025;53:D1516\u201325.","journal-title":"Nucleic Acids Res"},{"key":"1029_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform. 2012;4:17.","journal-title":"J Cheminform"},{"key":"1029_CR29","doi-asserted-by":"publisher","first-page":"e0132508","DOI":"10.1371\/journal.pone.0132508","volume":"10","author":"S DeLuca","year":"2015","unstructured":"DeLuca S, Khar K, Meiler J. Fully flexible docking of medium sized ligand libraries with RosettaLigand. PLoS One. 2015;10:e0132508.","journal-title":"PLoS One"},{"key":"1029_CR30","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/nprot.2013.074","volume":"8","author":"SA Combs","year":"2013","unstructured":"Combs SA, Deluca SL, Deluca SH, Lemmon GH, Nannemann DP, Nguyen ED, et al. Small-molecule ligand docking into comparative models with Rosetta. Nat Protoc. 2013;8:1277\u201398.","journal-title":"Nat Protoc"},{"key":"1029_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13321-015-0095-1","volume":"7","author":"S Kothiwale","year":"2015","unstructured":"Kothiwale S, Mendenhall JL, Meiler J. BCL::Conf: small molecule conformational sampling using a knowledge based rotamer library. J Cheminform. 2015;7:47.","journal-title":"J Cheminform"},{"key":"1029_CR32","doi-asserted-by":"publisher","first-page":"e63906","DOI":"10.1371\/journal.pone.0063906","volume":"8","author":"S Lyskov","year":"2013","unstructured":"Lyskov S, Chou FC, Conch\u00fair S\u00d3, Der BS, Drew K, Kuroda D, et al. Serverification of molecular modeling applications: the Rosetta Online Server that Includes Everyone (ROSIE). PLoS One. 2013;8:e63906.","journal-title":"PLoS One"},{"key":"1029_CR33","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","volume":"25","author":"PJA Cock","year":"2009","unstructured":"Cock PJA, Antao T, Chang JT, Chapman BA, Cox CJ, Dalke A, et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics. 2009;25:1422\u20133.","journal-title":"Bioinformatics"},{"key":"1029_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"1029_CR35","doi-asserted-by":"publisher","first-page":"e0232565","DOI":"10.1371\/journal.pone.0232565","volume":"15","author":"A Suarez-Arnedo","year":"2020","unstructured":"Suarez-Arnedo A, Torres Figueroa F, Clavijo C, Arbel\u00e1ez P, Cruz JC, Mu\u00f1oz-Camargo C. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS One. 2020;15:e0232565.","journal-title":"PLoS One"},{"key":"1029_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-0716-1350-4_1","volume":"2294","author":"SM Roth","year":"2021","unstructured":"Roth SM, Berens EB, Sharif GM, Glasgow E, Wellstein A. Cancer cell invasion and metastasis in zebrafish models (Danio rerio). Methods Mol Biol. 2021;2294:3\u201316.","journal-title":"Methods Mol Biol"},{"key":"1029_CR37","doi-asserted-by":"publisher","first-page":"2234140","DOI":"10.1080\/15384047.2023.2234140","volume":"24","author":"Y Dryer","year":"2023","unstructured":"Dryer Y, Berghausen J, Creswell K, Glasgow E, Brelidze TI. Comparison of tumor growth assessment using GFP fluorescence and DiI labeling in a zebrafish xenograft model. Cancer Biol Ther. 2023;24:2234140.","journal-title":"Cancer Biol Ther"},{"key":"1029_CR38","unstructured":"OECD. Test No. 236: Fish Embryo Acute Toxicity (FET) Test [Internet]. Paris: Organisation for Economic Co-operation and Development; 2013 [cited 2023 Oct 9]. Available from: https:\/\/www.oecd-ilibrary.org\/environment\/test-no-236-fish-embryo-acute-toxicity-fet-test_9789264203709-en"},{"key":"1029_CR39","doi-asserted-by":"crossref","unstructured":"Wang ZJ, Ghorbani M, Chen X, Tiwari PB, Klauda JB, Brelidze TI. Molecular mechanism of EAG1 channel inhibition by imipramine binding to the PAS domain. J Biol Chem [Internet]. 2023 [cited 2023 Nov 3];0(0). Available from: https:\/\/www.jbc.org\/article\/S0021-9258","DOI":"10.1016\/j.bpj.2023.11.1591"},{"key":"1029_CR40","doi-asserted-by":"publisher","first-page":"27989","DOI":"10.1074\/jbc.M109.016337","volume":"284","author":"TI Brelidze","year":"2009","unstructured":"Brelidze TI, Carlson AE, Zagotta WN. Absence of direct cyclic nucleotide modulation of mEAG1 and hERG1 channels revealed with fluorescence and electrophysiological methods. J Biol Chem. 2009;284:27989\u201397.","journal-title":"J Biol Chem"},{"key":"1029_CR41","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo S, Kim T, Iyer VG, Im W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem. 2008;29:1859\u201365.","journal-title":"J Comput Chem"},{"key":"1029_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/bs.apcsb.2014.06.002","volume":"96","author":"S Jo","year":"2014","unstructured":"Jo S, Cheng X, Islam SM, Huang L, Rui H, Zhu A, et al. CHARMM-GUI PDB manipulator for advanced modeling and simulations of proteins containing nonstandard residues. Adv Protein Chem Struct Biol. 2014;96:235\u201365.","journal-title":"Adv Protein Chem Struct Biol"},{"key":"1029_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2024.168554","volume":"436","author":"L Kong","year":"2024","unstructured":"Kong L, Park SJ, Im W. CHARMM-GUI PDB reader and manipulator: covalent ligand modeling and simulation. J Mol Biol. 2024;436:168554.","journal-title":"J Mol Biol"},{"key":"1029_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.167995","volume":"435","author":"SJ Park","year":"2023","unstructured":"Park SJ, Kern N, Brown T, Lee J, Im W. CHARMM-GUI PDB manipulator: various PDB structural modifications for biomolecular modeling and simulation. J Mol Biol. 2023;435:167995.","journal-title":"J Mol Biol"},{"key":"1029_CR45","doi-asserted-by":"publisher","first-page":"14261","DOI":"10.1021\/acs.jmedchem.2c01147","volume":"65","author":"PW Kenny","year":"2022","unstructured":"Kenny PW. Hydrogen-bond donors in drug design. J Med Chem. 2022;65:14261\u201375.","journal-title":"J Med Chem"},{"key":"1029_CR46","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1007\/s43440-021-00304-5","volume":"73","author":"A Loza-Huerta","year":"2021","unstructured":"Loza-Huerta A, Milo E, Picones A, Hern\u00e1ndez-Cruz A, Luis E. Thallium-sensitive fluorescent assay reveals loperamide as a new inhibitor of the potassium channel Kv10.1. Pharm Rep. 2021;73:1744\u201353.","journal-title":"Pharm Rep"},{"key":"1029_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jmor.1051360203","volume":"136","author":"JN Dumont","year":"1972","unstructured":"Dumont JN. Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals. J Morphol. 1972;136:153\u201379.","journal-title":"J Morphol"},{"key":"1029_CR48","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1021\/mp4000822","volume":"10","author":"A Mateus","year":"2013","unstructured":"Mateus A, Matsson P, Artursson P. Rapid measurement of intracellular unbound drug concentrations. Mol Pharm. 2013;10:2467\u201378.","journal-title":"Mol Pharm"},{"key":"1029_CR49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/npp.1993.50","volume":"9","author":"RJ Baldessarini","year":"1993","unstructured":"Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, Cohen BM. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology. 1993;9:117\u201324.","journal-title":"Neuropsychopharmacology"},{"key":"1029_CR50","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1176\/ajp.156.6.885","volume":"156","author":"J Kornhuber","year":"1999","unstructured":"Kornhuber J, Schultz A, Wiltfang J, Meineke I, Gleiter CH, Z\u00f6chling R, et al. Persistence of haloperidol in human brain tissue. Am J Psychiatry. 1999;156:885\u201390.","journal-title":"Am J Psychiatry"},{"key":"1029_CR51","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/0006-2952(77)90340-9","volume":"26","author":"P Seeman","year":"1977","unstructured":"Seeman P. Anti-schizophrenic drugs-membrane receptor sites of action. Biochem Pharm. 1977;26:1741\u20138.","journal-title":"Biochem Pharm"},{"key":"1029_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1085\/jgp.118.2.207","volume":"118","author":"S Crouzy","year":"2001","unstructured":"Crouzy S, Bern\u00e8che S, Roux B. Extracellular blockade of K(+) channels by TEA: results from molecular dynamics simulations of the KcsA channel. J Gen Physiol. 2001;118:207\u201318.","journal-title":"J Gen Physiol"},{"key":"1029_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0896-6273(92)90276-J","volume":"8","author":"L Heginbotham","year":"1992","unstructured":"Heginbotham L, MacKinnon R. The aromatic binding site for tetraethylammonium ion on potassium channels. Neuron. 1992;8:483\u201391.","journal-title":"Neuron"},{"key":"1029_CR54","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1113\/jphysiol.1995.sp020809","volume":"486","author":"SR Ikeda","year":"1995","unstructured":"Ikeda SR, Korn SJ. Influence of permeating ions on potassium channel block by external tetraethylammonium. J Physiol. 1995;486:267\u201372.","journal-title":"J Physiol"},{"key":"1029_CR55","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/jcp.25448","volume":"232","author":"F G\u00f3mez-Lagunas","year":"2017","unstructured":"G\u00f3mez-Lagunas F, Carrillo E, Pardo LA, St\u00fchmer W. Gating modulation of the tumor-related Kv10.1 channel by mibefradil. J Cell Physiol. 2017;232:2019\u201332.","journal-title":"J Cell Physiol"},{"key":"1029_CR56","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1002\/jcp.24095","volume":"227","author":"M Hammadi","year":"2012","unstructured":"Hammadi M, Chopin V, Matifat F, Dhennin-Duthille I, Chasseraud M, Sevestre H, et al. Human ether \u00e0-gogo K+ channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry. J Cell Physiol. 2012;227:3837\u201346.","journal-title":"J Cell Physiol"},{"key":"1029_CR57","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3892\/mmr.2017.6191","volume":"15","author":"CH Horst","year":"2017","unstructured":"Horst CH, Titze-de-Almeida R, Titze-de-Almeida SS. The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells. Mol Med Rep. 2017;15:1479\u201388.","journal-title":"Mol Med Rep"},{"key":"1029_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-109","volume":"10","author":"F Hartung","year":"2011","unstructured":"Hartung F, St\u00fchmer W, Pardo LA. Tumor cell-selective apoptosis induction through targeting of KV10.1 via bifunctional TRAIL antibody. Mol Cancer. 2011;10:109.","journal-title":"Mol Cancer"},{"key":"1029_CR59","doi-asserted-by":"publisher","first-page":"7343","DOI":"10.1158\/0008-5472.CAN-07-0107","volume":"67","author":"D G\u00f3mez-Varela","year":"2007","unstructured":"G\u00f3mez-Varela D, Zwick-Wallasch E, Kn\u00f6tgen H, S\u00e1nchez A, Hettmann T, Ossipov D, et al. Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res. 2007;67:7343\u20139.","journal-title":"Cancer Res"},{"key":"1029_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/cancers15010178","volume":"15","author":"R Canella","year":"2022","unstructured":"Canella R, Brugnoli F, Gallo M, Keillor JW, Terrazzan A, Ferrari E, et al. A multidisciplinary approach establishes a link between transglutaminase 2 and the Kv10.1 voltage-dependent K+ channel in breast cancer. Cancers (Basel). 2022;15:178.","journal-title":"Cancers (Basel)"},{"key":"1029_CR61","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","volume":"8","author":"H Dillek\u00e5s","year":"2019","unstructured":"Dillek\u00e5s H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases? Cancer Med. 2019;8:5574\u20136.","journal-title":"Cancer Med"},{"key":"1029_CR62","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1085\/jgp.200409041","volume":"124","author":"RE Garc\u00eda-Ferreiro","year":"2004","unstructured":"Garc\u00eda-Ferreiro RE, Kerschensteiner D, Major F, Monje F, St\u00fchmer W, Pardo LA. Mechanism of block of hEag1 K+ channels by imipramine and astemizole. J Gen Physiol. 2004;124:301\u201317.","journal-title":"J Gen Physiol"},{"key":"1029_CR63","doi-asserted-by":"publisher","first-page":"35565","DOI":"10.1074\/jbc.M112.363978","volume":"287","author":"R Stengel","year":"2012","unstructured":"Stengel R, Rivera-Milla E, Sahoo N, Ebert C, Bollig F, Heinemann SH, et al. Kcnh1 voltage-gated potassium channels are essential for early zebrafish development. J Biol Chem. 2012;287:35565\u201375.","journal-title":"J Biol Chem"},{"key":"1029_CR64","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/cancers11010064","volume":"11","author":"YW Cho","year":"2019","unstructured":"Cho YW, Kim EJ, Nyiramana MM, Shin EJ, Jin H, Ryu JH, et al. Paroxetine induces apoptosis of human breast cancer MCF-7 cells through Ca2+-and p38 MAP kinase-dependent ROS generation. Cancers (Basel). 2019;11:64.","journal-title":"Cancers (Basel)"},{"key":"1029_CR65","first-page":"15093","volume":"8","author":"GX Liu","year":"2015","unstructured":"Liu GX, Yu YC, He XP, Ren SN, Fang XD, Liu F, et al. Expression of eag1 channel associated with the aggressive clinicopathological features and subtype of breast cancer. Int J Clin Exp Pathol. 2015;8:15093\u20139.","journal-title":"Int J Clin Exp Pathol"},{"key":"1029_CR66","doi-asserted-by":"publisher","first-page":"10415","DOI":"10.3390\/ijms251910415","volume":"25","author":"A Adornetto","year":"2024","unstructured":"Adornetto A, Lagan\u00e0 ML, Satriano A, Licastro E, Corasaniti MT, Bagetta G, et al. The antidepressant drug amitriptyline affects human SH-SY5Y neuroblastoma cell proliferation and modulates autophagy. Int J Mol Sci. 2024;25:10415.","journal-title":"Int J Mol Sci"},{"key":"1029_CR67","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1097\/CAD.0b013e328364312f","volume":"24","author":"G Pula","year":"2013","unstructured":"Pula G, Pistilli A, Montagnoli C, Stabile AM, Rambotti MG, Rende M. The tricyclic antidepressant amitriptyline is cytotoxic to HTB114 human leiomyosarcoma and induces p75(NTR)-dependent apoptosis. Anticancer Drugs. 2013;24:899\u2013910.","journal-title":"Anticancer Drugs"},{"key":"1029_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ccell.2014.12.001","volume":"27","author":"N McGranahan","year":"2015","unstructured":"McGranahan N, Swanton C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell. 2015;27:15\u201326.","journal-title":"Cancer Cell"},{"key":"1029_CR69","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell. 2017;168:613\u201328.","journal-title":"Cell"},{"key":"1029_CR70","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.3390\/molecules27113513","volume":"27","author":"C Yang","year":"2022","unstructured":"Yang C, Mai Z, Liu C, Yin S, Cai Y, Xia C. Natural products in preventing tumor drug resistance and related signaling pathways. Molecules. 2022;27:3513.","journal-title":"Molecules"},{"key":"1029_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217116","volume":"598","author":"C Yang","year":"2024","unstructured":"Yang C, Deng X, Tang Y, Tang H, Xia C. Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment. Cancer Lett. 2024;598:217116.","journal-title":"Cancer Lett"},{"key":"1029_CR72","first-page":"1265","volume":"31","author":"I Restrepo-Angulo","year":"2011","unstructured":"Restrepo-Angulo I, S\u00e1nchez-Torres C, Camacho J. Human EAG1 potassium channels in the epithelial-to-mesenchymal transition in lung cancer cells. Anticancer Res. 2011;31:1265\u201370.","journal-title":"Anticancer Res"},{"key":"1029_CR73","doi-asserted-by":"publisher","first-page":"36234","DOI":"10.1074\/jbc.M801830200","volume":"283","author":"BR Downie","year":"2008","unstructured":"Downie BR, S\u00e1nchez A, Kn\u00f6tgen H, Contreras-Jurado C, Gymnopoulos M, Weber C, et al. Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. J Biol Chem. 2008;283:36234\u201340.","journal-title":"J Biol Chem"},{"key":"1029_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188355","volume":"1873","author":"S He","year":"2020","unstructured":"He S, Moutaoufik MT, Islam S, Persad A, Wu A, Aly KA, et al. HERG channel and cancer: a mechanistic review of carcinogenic processes and therapeutic potential. Biochim Biophys Acta Rev Cancer. 2020;1873:188355.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1029_CR75","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/sj.bjp.0703222","volume":"129","author":"SH Jo","year":"2000","unstructured":"Jo SH, Youm JB, Lee CO, Earm YE, Ho WK. Blockade of the HERG human cardiac K+ channel by the antidepressant drug amitriptyline. Br J Pharm. 2000;129:1474\u201380.","journal-title":"Br J Pharm"},{"key":"1029_CR76","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/ijms26030871","volume":"26","author":"MF Mart\u00ednez-L\u00f3pez","year":"2025","unstructured":"Mart\u00ednez-L\u00f3pez MF, L\u00f3pez-Gil JF. Small fish, big answers: zebrafish and the molecular drivers of metastasis. Int J Mol Sci. 2025;26:871.","journal-title":"Int J Mol Sci"},{"key":"1029_CR77","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature12111","volume":"496","author":"K Howe","year":"2013","unstructured":"Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013;496:498\u2013503.","journal-title":"Nature"},{"key":"1029_CR78","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri2017","volume":"7","author":"LD Shultz","year":"2007","unstructured":"Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol. 2007;7:118\u201330.","journal-title":"Nat Rev Immunol"},{"key":"1029_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173057","volume":"875","author":"C Xia","year":"2020","unstructured":"Xia C, He Z, Cai Y, Liang S. Vorinostat upregulates MICA via the PI3K\/Akt pathway to enhance the ability of natural killer cells to kill tumor cells. Eur J Pharm. 2020;875:173057.","journal-title":"Eur J Pharm"},{"key":"1029_CR80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejphar.2018.04.027","volume":"830","author":"C Xia","year":"2018","unstructured":"Xia C, Liang S, He Z, Zhu X, Chen R, Chen J. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1\/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells. Eur J Pharm. 2018;830:59\u201367.","journal-title":"Eur J Pharm"},{"key":"1029_CR81","unstructured":"Thour A, Marwaha R. Amitriptyline. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 July 2]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537225\/"},{"key":"1029_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1848-y","volume":"15","author":"R Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez R, St\u00fchmer W, Martin S, Schell J, Reichmann A, Rohde V, et al. Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival. BMC Cancer. 2015;15:839.","journal-title":"BMC Cancer"},{"key":"1029_CR83","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.bjc.6605996","volume":"104","author":"AJ Walker","year":"2011","unstructured":"Walker AJ, Card T, Bates TE, Muir K. Tricyclic antidepressants and the incidence of certain cancers: a study using the GPRD. Br J Cancer. 2011;104:193\u20137.","journal-title":"Br J Cancer"},{"key":"1029_CR84","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.neulet.2004.07.001","volume":"368","author":"S Patt","year":"2004","unstructured":"Patt S, Preussat K, Beetz C, Kraft R, Schrey M, Kalff R, et al. Expression of ether \u00e0 go-go potassium channels in human gliomas. Neurosci Lett. 2004;368:249\u201353.","journal-title":"Neurosci Lett"},{"key":"1029_CR85","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3748\/wjg.v13.i8.1257","volume":"13","author":"XW Ding","year":"2007","unstructured":"Ding XW, Yan JJ, An P, L\u00fc P, Luo HS. Aberrant expression of ether \u00e0 go-go potassium channel in colorectal cancer patients and cell lines. World J Gastroenterol. 2007;13:1257\u201361.","journal-title":"World J Gastroenterol"},{"key":"1029_CR86","doi-asserted-by":"publisher","first-page":"e0252779","DOI":"10.1371\/journal.pone.0252779","volume":"16","author":"N Karawekpanyawong","year":"2021","unstructured":"Karawekpanyawong N, Kaewkitikul K, Maneeton B, Maneeton N, Siriaree S. The prevalence of depressive disorder and its association in Thai cervical cancer patients. PLoS One. 2021;16:e0252779.","journal-title":"PLoS One"},{"key":"1029_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejca.2016.11.017","volume":"72","author":"TJ Hartung","year":"2017","unstructured":"Hartung TJ, Br\u00e4hler E, Faller H, H\u00e4rter M, Hinz A, Johansen C, et al. The risk of being depressed is significantly higher in cancer patients than in the general population: prevalence and severity of depressive symptoms across major cancer types. Eur J Cancer. 2017;72:46\u201353.","journal-title":"Eur J Cancer"},{"key":"1029_CR88","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1049909111412539","volume":"29","author":"S Mishra","year":"2012","unstructured":"Mishra S, Bhatnagar S, Goyal GN, Rana SPS, Upadhya SP. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care. 2012;29:177\u201382.","journal-title":"Am J Hosp Palliat Care"},{"key":"1029_CR89","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/1049909108322288","volume":"25","author":"S Mishra","year":"2008","unstructured":"Mishra S, Bhatnagar S, Gupta D, Nirwani Goyal G, Jain R, Chauhan H. Management of neuropathic cancer pain following WHO analgesic ladder: a prospective study. Am J Hosp Palliat Care. 2008;25:447\u201351.","journal-title":"Am J Hosp Palliat Care"},{"key":"1029_CR90","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/BF02333665","volume":"8","author":"V Ventafridda","year":"1987","unstructured":"Ventafridda V, Bonezzi C, Caraceni A, De Conno F, Guarise G, Ramella G, et al. Antidepressants for cancer pain and other painful syndromes with deafferentation component: comparison of amitriptyline and trazodone. Ital J Neurol Sci. 1987;8:579\u201387.","journal-title":"Ital J Neurol Sci"},{"key":"1029_CR91","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF02089958","volume":"14","author":"S Vandel","year":"1978","unstructured":"Vandel S, Vandel B, Sandoz M, Allers G, Bechtel P, Volmat R. Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline. Eur J Clin Pharm. 1978;14:185\u201390.","journal-title":"Eur J Clin Pharm"},{"key":"1029_CR92","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2165\/00003088-200241110-00004","volume":"41","author":"S Ulrich","year":"2002","unstructured":"Ulrich S, L\u00e4uter J. Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression. Clin Pharmacokinet. 2002;41:853\u201376.","journal-title":"Clin Pharmacokinet"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01029-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01029-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01029-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:03:37Z","timestamp":1786493017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01029-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":92,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01029-4","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The views expressed in this manuscript are those of the authors and do not reflect the official policy or position of the U.S. Naval Academy, Department of the Navy, the Department of War, or the U.S. Government.","order":2,"name":"Ethics","label":"Disclosure Statement","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal procedures were conducted in accordance with NIH guidelines for the care and use of laboratory animals and approved by the Georgetown University Institutional Animal Care and Use Committee (Protocol 2017-0078). No human participants were involved, and thus informed consent was not required.","order":3,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}